Skip to main content

Biotechnology Startups

Updated October 2026

Companies in the biotechnology sector developing innovative solutions and technologies.

Explore 5,823 recently funded biotechnology companies with verified founder contact information and fundraising data.

Total Companies
5,823
Total Funding
$1.9B
Avg Funding
$75.2M
Global Reach
8
countries

Top Cities for Biotechnology

Copenhagen
Donostia-san Sebastián
Seongnam
Loos
Boulder
Boston

Recently Funded Companies

Export
Copenhagen, Denmark

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

$157.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Donostia-san Sebastián, Spain

Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies

$3.5M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Seongnam, South Korea

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

$17.8M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Loos, France

Lattice Medical offers a 3D printed bioabsorbable medical device for breast reconstruction.

$49.9M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boulder, United States

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

$17.3M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.

$36.5M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.

$70.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Saint Paul, United States

Agitated Solutions is a healthcare company that delivers microbubble treatment for patients with hypoxemic respiratory failure.

$3.8M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Woburn, United States

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

$39.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cranberry Twp, United States

Jabez Biosciences develops clinical-stage cancer therapies, including small molecule drugs for solid and liquid tumors.

$1.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

$25.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Durham, United States

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.

$1.9M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Weave Bio is an AI-native platform transforming regulatory workflows and accelerating how novel therapies reach patients faster.

$20.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Marseille, France

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

$122.4M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Sunnyvale, United States

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.

$28.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.

$60.4M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States

Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.

$78.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

$31.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

St Louis, United States

Plastomics develops a new and better way to make the next generation of biotech crops using chloroplast engineering.

$5.8M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

$13.3M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Munich, Germany

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

$400.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Waltham, United States

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

$600.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Paris, France

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

$11.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.

$50.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Halifax, Canada

ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.

$35.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Showing 3201 to 3225 of 5,823 companies

About the Biotechnology Startup Ecosystem

The biotechnology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biotechnology

Biotechnology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biotechnology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biotechnology Funding Breakdown

Here is how funding is distributed among the 5,823 biotechnology companies tracked in the VCBacked database.

Average Funding
$75.2M
Total Funding Tracked
$1.9B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biotechnology

1.Boston
2 companies$67.5M
2.San Francisco
2 companies$45.0M
3.Copenhagen
1 companies$157.0M
4.Donostia-san Sebastián
1 companies$3.5M
5.Seongnam
1 companies$17.8M

Related Industries

Companies in the biotechnology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biotechnology Startups?

Perfect for: B2B sales teams targeting biotechnology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

5,823 Biotechnology Startups (2026) — Recently Funded — Page 129 | VCBacked